Full Description
Hulk Stack CJC-1295 (With DAC) and Ipamorelin (20mg)
The Hulk Stack CJC-1295 (With DAC) and Ipamorelin (20mg) is a dual-peptide research blend developed for laboratory investigations into growth hormone (GH) regulation and the somatotropic axis.
This formulation combines a long-acting growth hormone-releasing hormone (GHRH) analogue with a selective growth hormone secretagogue (GHS). The two compounds interact with different receptors involved in GH regulation, making their individual signalling mechanisms and pharmacological characteristics relevant areas of scientific research.
Key Component Profile
CJC-1295 (With DAC): A synthetic 30-amino-acid analogue of growth hormone-releasing hormone (GHRH). Its Drug Affinity Complex (DAC) enables binding to circulating albumin, extending its estimated half-life to approximately 5.8–8.1 days in published human studies. This prolonged activity has been investigated in research examining sustained GHRH receptor stimulation, growth hormone secretion and insulin-like growth factor 1 (IGF-1) regulation.
Ipamorelin: A synthetic pentapeptide that acts as an agonist of the growth hormone secretagogue receptor (GHSR-1a). Ipamorelin has been investigated for its selective effects on growth hormone release. Early research has examined its activity in comparison with other growth hormone secretagogues, including differences in ACTH and cortisol responses.
Research Applications & Mechanisms
-
Dual-Pathway Signalling: CJC-1295 interacts with GHRH receptors, while Ipamorelin acts through GHSR-1a receptors. These distinct mechanisms provide a basis for investigating different pathways involved in growth hormone regulation.
-
Pharmacokinetic Differences: CJC-1295 With DAC has a prolonged half-life due to its albumin-binding properties, whereas Ipamorelin is comparatively short-acting. These differences are relevant to research into peptide activity and endocrine signalling.
-
Growth Hormone Research: Both compounds have been studied individually for their effects on GH-related pathways. However, the effects of this specific combination require further investigation.
Key Features
-
Premium dual-peptide research formulation
-
20mg total peptide content
-
CJC-1295 With DAC and Ipamorelin combination
-
Independently third-party lab tested
-
Quality and purity information available through laboratory reports
-
Suitable for scientific and laboratory research
-
Fast UK dispatch
-
Free next-day UK delivery
Research Applications
This research blend is intended for controlled laboratory investigations involving areas such as:
-
Growth hormone regulation and signalling
-
GHRH receptor activity
-
Growth hormone secretagogue receptor (GHSR-1a) interactions
-
Somatotropic axis research
-
Peptide pharmacokinetics
-
Peptide-receptor interactions
-
Endocrine signalling pathways
-
Preclinical peptide research
Quality You Can Trust
At Supreme Peptides, quality, consistency and transparency are central to our research peptide range. The Hulk Stack CJC-1295 (With DAC) and Ipamorelin (20mg) is carefully sourced and supported by independent third-party laboratory testing.
Researchers can review our peptide lab reports online for further information regarding product quality and purity.
Important Notice
For laboratory and research use only.
The Hulk Stack is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.